ZA971964B - Azolobenzazepine derivatives and compositions and method of use thereof. - Google Patents
Azolobenzazepine derivatives and compositions and method of use thereof.Info
- Publication number
- ZA971964B ZA971964B ZA9701964A ZA971964A ZA971964B ZA 971964 B ZA971964 B ZA 971964B ZA 9701964 A ZA9701964 A ZA 9701964A ZA 971964 A ZA971964 A ZA 971964A ZA 971964 B ZA971964 B ZA 971964B
- Authority
- ZA
- South Africa
- Prior art keywords
- azolobenzazepine
- derivatives
- compositions
- azolobenzazepine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1352896P | 1996-03-08 | 1996-03-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA971964B true ZA971964B (en) | 1997-09-08 |
Family
ID=21760422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9701964A ZA971964B (en) | 1996-03-08 | 1997-03-06 | Azolobenzazepine derivatives and compositions and method of use thereof. |
Country Status (13)
Country | Link |
---|---|
US (2) | US6124281A (no) |
EP (1) | EP0888350A1 (no) |
JP (1) | JP2000506160A (no) |
KR (1) | KR19990087585A (no) |
CN (1) | CN1084747C (no) |
AU (1) | AU723860B2 (no) |
CA (1) | CA2247453A1 (no) |
IL (1) | IL126095A0 (no) |
NO (1) | NO984106L (no) |
NZ (1) | NZ330973A (no) |
TW (1) | TW486480B (no) |
WO (1) | WO1997032883A1 (no) |
ZA (1) | ZA971964B (no) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1155599C (zh) * | 1997-09-29 | 2004-06-30 | 明治制果株式会社 | 三环三唑并苯并氮杂�衍生物、用于制备该衍生物的方法和抗变态反应剂 |
US7919109B2 (en) * | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
CN1275968C (zh) | 2001-12-26 | 2006-09-20 | 明治制果株式会社 | 三环型三唑并苯并氮杂䓬衍生物的非晶态物质 |
MXPA04007606A (es) * | 2002-02-07 | 2004-11-10 | Neurogen Corp | Arilamidas de acido pirazolcarboxilico fusionadas substituidas y compuestos relacionados. |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
JP4467616B2 (ja) | 2004-05-14 | 2010-05-26 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | Auroraキナーゼの阻害により有糸分裂の進行を阻止するための化合物および方法 |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
KR101106510B1 (ko) | 2006-05-30 | 2012-01-20 | 인타르시아 세라퓨틱스 인코포레이티드 | 투피스, 내부채널 삼투압 전달 시스템 유동 조절기 |
DK2049081T3 (da) | 2006-08-09 | 2013-02-25 | Intarcia Therapeutics Inc | Osmotiske leveringssystemer og stempelarrangementer |
CL2007003244A1 (es) * | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
ES2402172T3 (es) | 2007-04-23 | 2013-04-29 | Intarcia Therapeutics, Inc | Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
RU2535032C2 (ru) | 2008-12-22 | 2014-12-10 | Милленниум Фармасьютикалз, Инк. | Сочетание ингибиторов аврора киназы и анти-cd 20 антител |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
CN107638562B (zh) | 2009-09-28 | 2022-12-02 | 精达制药公司 | 基本稳态药物递送的快速建立和/或终止 |
JP2013520424A (ja) | 2010-02-19 | 2013-06-06 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | ナトリウム4−{[9−クロロ−7−(2−フルオロ−6−メトキシフェニル)−5H−ピリミド[5,4−d][2]ベンゾアゼピン−2−イル]アミノ}−2−メトキシベンゾエートの結晶形 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
CN105209042B (zh) | 2013-03-22 | 2019-03-08 | 米伦纽姆医药公司 | 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合 |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
US10925639B2 (en) | 2015-06-03 | 2021-02-23 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
BR112018073511A2 (pt) | 2016-05-16 | 2019-03-26 | Intarcia Therapeutics, Inc. | polipeptídeos seletivos do receptor de glucagon e métodos de uso dos mesmos |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
MX2019008006A (es) | 2017-01-03 | 2019-08-29 | Intarcia Therapeutics Inc | Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311948D0 (en) * | 1993-06-10 | 1993-07-28 | Zeneca Ltd | Substituted nitrogen heterocycles |
WO1995018130A1 (fr) * | 1993-12-28 | 1995-07-06 | Meiji Seika Kabushiki Kaisha | Derives tricycliques de benzazepine et benzothiazepine |
JP3537446B2 (ja) * | 1995-06-15 | 2004-06-14 | 明治製菓株式会社 | 三環性ベンゾアゼピン化合物 |
-
1997
- 1997-03-04 CN CN97192864A patent/CN1084747C/zh not_active Expired - Fee Related
- 1997-03-04 NZ NZ330973A patent/NZ330973A/xx unknown
- 1997-03-04 IL IL12609597A patent/IL126095A0/xx unknown
- 1997-03-04 AU AU22253/97A patent/AU723860B2/en not_active Ceased
- 1997-03-04 US US09/142,221 patent/US6124281A/en not_active Expired - Fee Related
- 1997-03-04 CA CA002247453A patent/CA2247453A1/en not_active Abandoned
- 1997-03-04 KR KR1019980707026A patent/KR19990087585A/ko not_active Application Discontinuation
- 1997-03-04 TW TW086102601A patent/TW486480B/zh active
- 1997-03-04 JP JP9531562A patent/JP2000506160A/ja not_active Ceased
- 1997-03-04 WO PCT/GB1997/000592 patent/WO1997032883A1/en not_active Application Discontinuation
- 1997-03-04 EP EP97905327A patent/EP0888350A1/en not_active Withdrawn
- 1997-03-06 ZA ZA9701964A patent/ZA971964B/xx unknown
-
1998
- 1998-09-07 NO NO984106A patent/NO984106L/no not_active Application Discontinuation
-
2000
- 2000-09-22 US US09/668,261 patent/US6313290B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6124281A (en) | 2000-09-26 |
US6313290B1 (en) | 2001-11-06 |
AU2225397A (en) | 1997-09-22 |
CA2247453A1 (en) | 1997-09-12 |
NO984106L (no) | 1998-11-06 |
NO984106D0 (no) | 1998-09-07 |
AU723860B2 (en) | 2000-09-07 |
IL126095A0 (en) | 1999-05-09 |
TW486480B (en) | 2002-05-11 |
WO1997032883A1 (en) | 1997-09-12 |
JP2000506160A (ja) | 2000-05-23 |
CN1224424A (zh) | 1999-07-28 |
EP0888350A1 (en) | 1999-01-07 |
CN1084747C (zh) | 2002-05-15 |
KR19990087585A (ko) | 1999-12-27 |
NZ330973A (en) | 2000-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
GB9616411D0 (en) | Shampoo compositions and method | |
GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
GB2319250B (en) | Derivatives of 6,8-Difluoro-7-Hydroxycoumarin | |
HUP0101172A3 (en) | Ortho-anthranilamide derivatives and their use as anti-coagulants | |
PL331900A1 (en) | 1,4-heterocyclic inhibitors of metaloprotease | |
PL329875A1 (en) | Derivatives of carbolin | |
HK1112180A1 (en) | Pharmaceutical use and compositions involving isoflavones | |
PL331838A1 (en) | 1,3-diheterocyclic inhibitors of metaloproteases | |
HK1034906A1 (en) | Method and composition of an oral preparation of itraconazole. | |
ZA989400B (en) | Method and composition | |
PH31270A (en) | Superplasticizer-concrete composition and method of preparation. | |
GB2346823B (en) | Reamer and method of using the same | |
GB9624501D0 (en) | Insecticial compositions and method | |
EP0801648A4 (en) | SUBSTITUTED DERIVATIVES OF 2-ARYLCARBONYLOXYMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE, COMPOSITIONS CONTAINING THEM AND METHODS OF USE | |
IL128614A0 (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
AU1841195A (en) | 1-beta -methyl-carbapenem, compositions containing same and methods of use | |
EP1139981A4 (en) | COMPOSITIONS AND RELATED METHODS OF USE | |
AU3200197A (en) | New composition and methods | |
GB9420616D0 (en) | Method, compositions and use | |
GB2318356B (en) | Composition and method | |
IL120488A (en) | Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions | |
PL319070A1 (en) | Derivatives of 1,25-dihydroxy-16,22,23-trisdehyrochoecalcifero, method of obtaining them and compositions containing such derivatives | |
AU4217497A (en) | Skap55 compositions and methods of use therefor | |
GB9603766D0 (en) | 2-(Fluroenonyl) - carbapenems, compositions and methods of use |